Defining and conceptualising the commercial determinants of health

Anna B. Gilmore*, Alice Fabbri, Fran Baum, Adam Bertscher, Krista Bondy, Ha Joon Chang, Sandro Demaio, Agnes Erzse, Nicholas Freudenberg, Sharon Friel, Karen J. Hofman, Paula Johns, Safura Abdool Karim, Jennifer Lacy-Nichols, Camila Maranha Paes de Carvalho, Robert Marten, Martin McKee, Mark Petticrew, Lindsay Robertson, Viroj TangcharoensathienAnne Marie Thow

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    226 Citations (Scopus)

    Abstract

    Although commercial entities can contribute positively to health and society there is growing evidence that the products and practices of some commercial actors—notably the largest transnational corporations—are responsible for escalating rates of avoidable ill health, planetary damage, and social and health inequity; these problems are increasingly referred to as the commercial determinants of health. The climate emergency, the non-communicable disease epidemic, and that just four industry sectors (ie, tobacco, ultra-processed food, fossil fuel, and alcohol) already account for at least a third of global deaths illustrate the scale and huge economic cost of the problem. This paper, the first in a Series on the commercial determinants of health, explains how the shift towards market fundamentalism and increasingly powerful transnational corporations has created a pathological system in which commercial actors are increasingly enabled to cause harm and externalise the costs of doing so. Consequently, as harms to human and planetary health increase, commercial sector wealth and power increase, whereas the countervailing forces having to meet these costs (notably individuals, governments, and civil society organisations) become correspondingly impoverished and disempowered or captured by commercial interests. This power imbalance leads to policy inertia; although many policy solutions are available, they are not being implemented. Health harms are escalating, leaving health-care systems increasingly unable to cope. Governments can and must act to improve, rather than continue to threaten, the wellbeing of future generations, development, and economic growth.

    Original languageEnglish
    Pages (from-to)1194-1213
    Number of pages20
    JournalThe Lancet
    Volume401
    Issue number10383
    DOIs
    Publication statusPublished - 8 Apr 2023

    Fingerprint

    Dive into the research topics of 'Defining and conceptualising the commercial determinants of health'. Together they form a unique fingerprint.

    Cite this